Literature DB >> 8144397

Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts.

K Gohji1, M Nakajima, A Fabra, C D Bucana, A C von Eschenbach, T Tsuruo, I J Fidler.   

Abstract

We have recently established a human renal cell carcinoma KG-2 line that is tumorigenic in the subcutis (ectopic) and kidney (orthotopic) of nude mice but spontaneously metastasizes to the lung only after orthotopic implantation. KG-2 cells growing in the kidney (orthotopic) and lung metastases secreted higher levels of gelatinase than did cells growing in the subcutis (ectopic). We examined whether organ-specific fibroblasts play a role in the regulation of gelatinase production and invasion by renal carcinoma cells. The gelatinase level in the culture supernatants of KG-2 cells was increased by their cultivation with mouse kidney or lung fibroblasts. In contrast, cocultivation of KG-2 cells with mouse skin fibroblasts resulted in a significant reduction of gelatinase activity. Similar results were obtained by culturing KG-2 cells in the media conditioned by the different mouse fibroblasts. We, therefore, investigated effects on KG-2 cells of cytokines and growth factors known to be produced by fibroblasts of various origins. Of ten cytokines and growth factors tested, basic fibroblast growth factor, hepatocyte growth factor, and transforming growth factor-beta 1 (TGF-beta 1) stimulated gelatinase expression by the cultured KG-2 cells. Parallel immunohistochemical analyses revealed that mouse kidney and lung fibroblasts produced higher levels of TGF-beta 1 than did skin fibroblasts. These results indicate that gelatinase production by KG-2 renal cell carcinoma cells is influenced by the organ microenvironment. Specifically, organ-specific fibroblasts regulate the production of degradative enzymes by KG-2 cells and, hence, profoundly influence their invasive and metastatic capacity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144397      PMCID: PMC5919427          DOI: 10.1111/j.1349-7006.1994.tb02076.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  54 in total

1.  The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.

Authors:  W G Stetler-Stevenson; H C Krutzsch; M P Wacher; I M Margulies; L A Liotta
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

2.  Clonal growth of tumors on tissue-specific biomatrices and correlation with organ site specificity of metastases.

Authors:  R Doerr; I Zvibel; D Chiuten; J D'Olimpio; L M Reid
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

3.  Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

Authors:  D R Welch; A Fabra; M Nakajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Metastatic potential of human colorectal carcinomas implanted into nude mice: prediction of clinical outcome in patients operated upon for cure.

Authors:  J M Jessup; R Giavazzi; D Campbell; K R Cleary; K Morikawa; R Hostetter; E N Atkinson; I J Fidler
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

5.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

6.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.

Authors:  C M Overall; J L Wrana; J Sodek
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

7.  Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase.

Authors:  L I Fessler; K G Duncan; J H Fessler; T Salo; K Tryggvason
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

Review 8.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

9.  Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.

Authors:  P B Gordon; H U Choi; G Conn; A Ahmed; B Ehrmann; L Rosenberg; V B Hatcher
Journal:  J Cell Physiol       Date:  1989-09       Impact factor: 6.384

10.  Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro.

Authors:  J L Gross; D Moscatelli; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  11 in total

1.  Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.

Authors:  K Shibata; F Kikkawa; A Nawa; K Tamakoshi; N Suganuma; Y Tomoda
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activity.

Authors:  A Ladányi; J O Nagy; A Jeney; J Tímár
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  Organ-site dependence for the production of urokinase-type plasminogen activator and metastasis by human renal cell carcinoma cells.

Authors:  K Gohji; M Nakajima; D Boyd; C P Dinney; C D Bucana; S Kitazana; S Kamidono; I J Fidler
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.

Authors:  R K Singh; M Gutman; C D Bucana; R Sanchez; N Llansa; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

Review 5.  Invasion and metastasis.

Authors:  D Boyd
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

6.  A murine model of bone marrow micrometastasis in breast cancer.

Authors:  Barbara O'Kane Murphy; Shantaram Joshi; Anne Kessinger; Elizabeth Reed; J Graham Sharp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

7.  Evaluation of a reductively activated duocarmycin prodrug against murine and human solid cancers.

Authors:  George A Vielhauer; Megan Swink; Nikhil K Parelkar; James P Lajiness; Amanda L Wolfe; Dale Boger
Journal:  Cancer Biol Ther       Date:  2013-06       Impact factor: 4.742

8.  Establishment of high- and low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS.

Authors:  K Okumura; A Konishi; M Tanaka; M Kanazawa; K Kogawa; Y Niitsu
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 9.  A critical review of lipid-based nanoparticles for taxane delivery.

Authors:  Lan Feng; Russell J Mumper
Journal:  Cancer Lett       Date:  2012-07-13       Impact factor: 8.679

10.  Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.

Authors:  Y Mizushima; K Sassa; T Hamazaki; T Fujishita; R Oosaki; M Kobayashi
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.